Median Technologies SA
PAR:ALMDT
Gross Margin
Median Technologies SA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| FR |
|
Median Technologies SA
PAR:ALMDT
|
109.3m EUR |
104%
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
45.6B USD |
76%
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
83%
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
31.2B AUD |
100%
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
13.8B USD |
90%
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.6T JPY |
53%
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.8B USD |
67%
|
|
| SE |
|
Sectra AB
STO:SECT B
|
59.8B SEK |
52%
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
257.6B INR | N/A | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
20.4B CNY |
39%
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
66%
|
Median Technologies SA
Glance View
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Median Technologies SA's most recent financial statements, the company has Gross Margin of 103.9%.
You don't have any saved screeners yet